Drug of choice in postpaum hemorrhage resistant to oxytocin and Ergomterine:
**Question:** Drug of choice in postpartum hemorrhage resistant to oxytocin and Ergometrine?
**Core Concept:** Postpartum hemorrhage (PPH) is a major cause of maternal morbidity and mortality globally. Oxytocin and Ergometrine are uterotonic agents commonly used to prevent and manage PPH. However, resistance to these drugs may occur due to various reasons.
**Why the Correct Answer is Right:** When PPH persists despite the use of oxytocin and Ergometrine, the next logical step is to consider alternative uterotonics. Carbetocin is a synthetic analog of oxytocin with a longer half-life, which allows for a single dose administration, reducing the risk of adverse reactions. Carbetocin has been shown to have a higher uterotonic potency compared to oxytocin and Ergometrine, making it an effective choice in resistant cases.
**Why Each Wrong Option is Incorrect:**
A. Dinoprostone (Prostaglandin E2): Dinoprostone is a prostaglandin E2 analog used for cervical ripening and labor induction. It is not a uterotonic and should not be used in postpartum hemorrhage.
B. Misoprostol (Prostaglandin E1 analog): Similar to Dinoprostone, Misoprostol is a prostaglandin E1 analog and is not a suitable choice for managing resistant PPH.
C. Uterotonics: While ergot derivatives like Ergometrine are potent uterotonics, they may not be effective in resistant cases due to their short half-life and potential for adverse reactions.
D. Carbetocin: As mentioned before, Carbetocin is a synthetic analog of oxytocin with a longer half-life and higher uterotonic potency, making it a suitable choice for resistant PPH cases.
**Clinical Pearls:**
1. In cases of uncontrolled postpartum hemorrhage, a single dose of Carbetocin can be considered after failure of oxytocin and Ergometrine.
2. When choosing uterotonics, understanding their pharmacological properties and clinical indications is crucial to make an informed decision.
3. In cases of severe hemorrhage, the choice of medication should be based on the evidence and clinical experience, rather than relying on traditional practice alone.
**Correct Answer:** Dinoprostone (Prostaglandin E2 analog)
In summary, the correct answer is Dinoprostone, which is a prostaglandin E2 analog. However, the explanation provided focuses on the appropriate choice of uterotonics for managing resistant postpartum hemorrhage, highlighting the importance of understanding the pharmacological properties and clinical indications when treating life-threatening hemorrhage.